TY - JOUR T1 - ABOLITION OF EPINEPHRINE INACTIVATING PROPERTIES OF LIVER BY INHIBITORS OF MONOAMINE OXIDASE JF - Journal of Pharmacology and Experimental Therapeutics JO - J Pharmacol Exp Ther SP - 282 LP - 286 VL - 116 IS - 3 AU - E. C. GRIESEMER AU - J. A. WELLS Y1 - 1956/03/01 UR - http://jpet.aspetjournals.org/content/116/3/282.abstract N2 - Monoamine oxidase inhibitors, iprornazid and choline-p-tolyl ether, have been shown to prevent completely the ability of liver tissue to inactivate epinephrine. No evidence is found for systems insusceptible to monoamine oxidase inhibitors which might explain the inability of such agents to potentiate biological responses to epinephrine. © 1956, by The Williams & Wilkins Company ER -